Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses circulating nucleic acids, circulating tumor cells (CTC), and exosomes as biomarkers for diagnosis of cancer. Increasing demand for non-invasive diagnostic procedures is expected to boost growth of the global liquid biopsy market over the forecast period. Furthermore, increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period.
Key features of the study
• This report provides in-depth analysis of the global Liquid Biopsy and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Liquid Biopsy based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Liquid Biopsy report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
• By Biomarker Type
o CTC (Circulating Tumor Cells)
o ctNA (Circulating Tumor Nucliec Acids)
o Exosomes
• By Device Type
o Blood
o Urine
o Others
• By Disease Indication
o Lung Cancer
o Prostate Cancer
o Gastrointestinal Cancer
o Breast Cancer
o Colorectal Cancer
o Leukemia
o Others
• By End User
o Hospitals
o Cancer Institutes
o Academic Institutes
o Diagnostic Centers
• Global Liquid Biopsy Market, By Region
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 South Africa
 Central Africa
 North Africa
• Key Players
o Biocept, Inc.
o Qiagen N.V.
o Trovagene, Inc.
o Janssen Global Services
o LLC, MDxHealth SA, Natera, Inc.
o F. Hoffmann-La Roche Ltd.
o Silicon Biosystems
o Pathway Genomics Corporation
o Sysmex Corporation

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Biomarker Type
 Market Snippet, By Sample Type
 Market Snippet, By Disease Indication
 Market Snippet, By End User
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Key Developments
o Technological Advancement
o Regulatory Scenario
4. Global Liquid Biopsy Market, By Biomarker Type, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o CTC (Circulating Tumor Cells)
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o ctNA (Circulating Tumor Nucliec Acids)
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Exosomes
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
5. Global Liquid Biopsy Market, By Sample Type, 2021 – 2033 (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o Blood
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Urine
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
6. Global Liquid Biopsy Market, By Disease Indication 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Lung Cancer
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Gastrointestinal Cancer
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Prostate Cancer
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Breast Cancer
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Colorectal Cancer
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Leukemia
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Others
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
7. Global Liquid Biopsy Market, By End User 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Hospitals
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Cancer Institutes
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Academic Institutes
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Diagnostic Centers
 Introduction
 Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
8. Global Liquid Biopsy Market, By Region, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, By Region, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o U.S.
o Canada
o Latin America
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
 Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Company Profiles
 Biocept, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Qiagen N.V
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Trovagene, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Janssen Global Services, LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 MDxHealth SA
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Natera, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 F. Hoffmann-La Roche Ltd
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Silicon Biosystems
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Pathway Genomics Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Sysmex Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 24 market data tables and 20 figures on “Liquid Biopsy – Global forecast to 2033.